Major Article - BIT225, in combination with 3-drug antiretroviral therapy, page-211

https://hotcopper.com.au/threads/bill-gates-mg-foundation-biotron.5631005/page-222?post_id=48007676

We have been through this already. Here are your theories regarding BIT's failed hepatitis C program when you were trying to convince people to buy.

You could not have been more wrong if you tried!

Your views on things seem to flip flop on a dime and people can make up their own mind why this might be. It obviously has absolutely nothing to do with trying to support a trading position of course.

If you were honest and said things like, "if BIT succeeds with its compounds then it could do very well, but the reality is the chances of this happening are very very small", then perhaps I could take you seriously.